Literature DB >> 25026096

Effects of mild to moderate sedation on saccadic eye movements.

C Busettini1, M A Frölich2.   

Abstract

Sedatives alter the metrics of saccadic eye movements. If these effects are nonspecific consequences of sedation, like drowsiness and loss of attention to the task, or differ between sedatives is still unresolved. A placebo-controlled multi-step infusion of one of three sedatives, propofol or midazolam, both GABA-A agonists, or dexmedetedomidine, an α2-adrenergic agonist, was adopted to compare the effects of these three drugs in exactly the same experimental conditions. 60 healthy human volunteers, randomly divided in 4 groups, participated in the study. Each infusion step, delivered by a computer-controlled infusion pump, lasted 20min. During the last 10min of each step, the subject executed a saccadic task. Target concentration was doubled at each step. This block was repeated until the subject was too sedated to continue or for a maximum of 6 blocks. Subjects were unaware which infusion they were receiving. A video eye tracker was used to record the movements of the right eye. Saccadic parameters were modeled as a function of block number, estimated sedative plasma concentration, and subjective evaluation of sedation. Propofol and midazolam had strong effects on the dynamics and latency of the saccades. Midazolam, and to a less extent, propofol, caused saccades to become increasingly hypometric. Dexmedetedomidine had less impact on saccadic metrics and presented no changes in saccadic gain. Suppression of the sympathetic system associated with dexmedetomidine has different effects on eye movements from the increased activity of the inhibitory GABA-A receptors by propofol and midazolam even when the subjects reported similar sedation level.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Human; Main sequence; Oculomotor; Saccade; Sedative

Mesh:

Substances:

Year:  2014        PMID: 25026096      PMCID: PMC4138721          DOI: 10.1016/j.bbr.2014.07.012

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  55 in total

1.  Discharge patterns in nucleus prepositus hypoglossi and adjacent medial vestibular nucleus during horizontal eye movement in behaving macaques.

Authors:  J L McFarland; A F Fuchs
Journal:  J Neurophysiol       Date:  1992-07       Impact factor: 2.714

2.  Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil.

Authors:  D M Ball; P Glue; S Wilson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Attenuation of delay-period activity of monkey prefrontal neurons by an alpha2-adrenergic antagonist during an oculomotor delayed-response task.

Authors:  T Sawaguchi
Journal:  J Neurophysiol       Date:  1998-10       Impact factor: 2.714

4.  Analysis of the step response of the saccadic feedback: computational models.

Authors:  B Breznen; J W Gnadt
Journal:  Exp Brain Res       Date:  1997-11       Impact factor: 1.972

Review 5.  The microscopic anatomy and physiology of the mammalian saccadic system.

Authors:  A K Moschovakis; C A Scudder; S M Highstein
Journal:  Prog Neurobiol       Date:  1996-10       Impact factor: 11.685

6.  Comparison of arterialized venous with arterial blood propofol concentrations during sub-anaesthetic infusions in volunteers.

Authors:  K R Johnston; M D Vickers; W W Mapleson
Journal:  Br J Anaesth       Date:  1996-03       Impact factor: 9.166

7.  Action of dexmedetomidine on rat locus coeruleus neurones: intracellular recording in vitro.

Authors:  T H Chiu; M J Chen; Y R Yang; J J Yang; F I Tang
Journal:  Eur J Pharmacol       Date:  1995-10-24       Impact factor: 4.432

8.  Lateralization and functional organization of the locus coeruleus projection to the trigeminal somatosensory pathway in rat.

Authors:  K L Simpson; D W Altman; L Wang; M L Kirifides; R C Lin; B D Waterhouse
Journal:  J Comp Neurol       Date:  1997-08-18       Impact factor: 3.215

9.  Evaluation of saccadic eye movements as an objective test of recovery from anaesthesia.

Authors:  O Paut; J L Vercher; O Blin; B Lacarelle; D Mestre; A Durand; G M Gauthier; J Camboulives
Journal:  Acta Anaesthesiol Scand       Date:  1995-11       Impact factor: 2.105

10.  Neurotransmitter profile of saccadic omnipause neurons in nucleus raphe interpositus.

Authors:  A K Horn; J A Büttner-Ennever; P Wahle; I Reichenberger
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

View more
  7 in total

1.  Effects of GABAA kinetics on cortical population activity: computational studies and physiological confirmations.

Authors:  Sandrine Chemla; Frédéric Chavane
Journal:  J Neurophysiol       Date:  2016-02-24       Impact factor: 2.714

2.  Caffeine increases the velocity of rapid eye movements in unfatigued humans.

Authors:  Charlotte J W Connell; Benjamin Thompson; Jason Turuwhenua; Robert F Hess; Nicholas Gant
Journal:  Psychopharmacology (Berl)       Date:  2017-05-24       Impact factor: 4.530

3.  The Effect of Sedation on Cortical Activation: A Randomized Study Comparing the Effects of Sedation With Midazolam, Propofol, and Dexmedetomidine on Auditory Processing.

Authors:  Michael A Frölich; Catiffaney Banks; Timothy J Ness
Journal:  Anesth Analg       Date:  2017-05       Impact factor: 5.108

4.  Parametric Covariability in the Standard Model of the Saccadic Main Sequence.

Authors:  Claudio Busettini; Jennifer Braswell Christy
Journal:  Optom Vis Sci       Date:  2018-11       Impact factor: 1.973

5.  The Area under the Main Sequence as an Alternative Method to Measure Saccadic Dynamics.

Authors:  Claudio Busettini; Jennifer Braswell Christy
Journal:  Optom Vis Sci       Date:  2018-11       Impact factor: 1.973

6.  Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.

Authors:  Sushant Puri; Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2017-11-28

7.  Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.

Authors:  Charlotte Bakker; Michiel J van Esdonk; Rik F E Stuurman; Laura G J M Borghans; Marieke L de Kam; Joop M A van Gerven; Geert Jan Groeneveld
Journal:  J Clin Pharmacol       Date:  2021-07-29       Impact factor: 3.126

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.